IL74950A - Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives - Google Patents

Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives

Info

Publication number
IL74950A
IL74950A IL74950A IL7495085A IL74950A IL 74950 A IL74950 A IL 74950A IL 74950 A IL74950 A IL 74950A IL 7495085 A IL7495085 A IL 7495085A IL 74950 A IL74950 A IL 74950A
Authority
IL
Israel
Prior art keywords
hydroxypyrone
derivatives
pharmaceutical compositions
iron complexes
complexes
Prior art date
Application number
IL74950A
Other languages
English (en)
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of IL74950A publication Critical patent/IL74950A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL74950A 1984-04-19 1985-04-17 Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives IL74950A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848410290A GB8410290D0 (en) 1984-04-19 1984-04-19 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL74950A true IL74950A (en) 1988-11-30

Family

ID=10559911

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74950A IL74950A (en) 1984-04-19 1985-04-17 Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives

Country Status (11)

Country Link
US (1) US5028411A (fr)
EP (1) EP0159917B1 (fr)
JP (1) JPS60252414A (fr)
AU (1) AU582510B2 (fr)
CA (1) CA1253803A (fr)
DE (1) DE3571549D1 (fr)
DK (1) DK175685A (fr)
GB (2) GB8410290D0 (fr)
IL (1) IL74950A (fr)
NZ (1) NZ211789A (fr)
ZA (1) ZA852831B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1313997C (fr) * 1986-04-11 1993-03-02 Hideo Anraku Accelerateur de l'activite de l'hydrolase
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
US6165495A (en) * 1994-04-29 2000-12-26 Blankenship; Mildred Drug delivery system
ATE273702T1 (de) * 1995-06-10 2004-09-15 Vitra Pharmaceuticals Ltd Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
WO2000016736A1 (fr) * 1998-09-23 2000-03-30 Unilever N.V. Compositions convenant aux soins buccaux
US6261600B1 (en) 1999-04-30 2001-07-17 Drugtech Corporation Folic acid supplement
US7135196B2 (en) 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
US6680016B2 (en) * 2001-08-17 2004-01-20 University Of Dayton Method of forming conductive polymeric nanocomposite materials
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US6662911B1 (en) 2002-11-07 2003-12-16 John G. Nugier Brake shoe rivet
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
JP2007517054A (ja) * 2003-12-31 2007-06-28 シーマ・ラブス、インコーポレイテッド 概して線状の発泡性経口フェンタニル投薬形態および投与方法
BRPI0418213A (pt) * 2003-12-31 2007-04-27 Cima Labs Inc forma de dosagem, e, método para tratar dor em um paciente em necessidade do mesmo
US20080113899A1 (en) * 2004-01-14 2008-05-15 Gekkeikan Sake Co., Ltd. Iron Supplement and Utilization of the Same
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
US20150024070A1 (en) * 2013-07-18 2015-01-22 Plato Chun-Chih Lee Ingestible canker sore treatment
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904573A (en) * 1957-05-06 1959-09-15 Ortho Pharma Corp Ferrous citrate complex
US2865938A (en) * 1957-09-25 1958-12-23 Hyman Rosenstein Iron choline compound and production thereof
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR2130M (fr) * 1962-04-25 1963-11-12 Rech S Appliquees Soc D Expl Médicament a base d'une solution aqueuse stable de chlorure ferreux et d'acide ascorbique.
FR1500765A (fr) * 1963-09-19 1967-11-10 Pfizer & Co C Dérivés de l'acide pyroméconique et procédé pour leur préparation
US3338718A (en) * 1963-10-17 1967-08-29 Pfizer & Co C Animal feeds containing maltol
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
DE2613500A1 (de) * 1975-04-01 1976-10-21 Procter & Gamble Mundpflegemittel und verfahren zur verhinderung von verfaerbungen der zaehne
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4018934A (en) * 1975-08-25 1977-04-19 General Foods Corporation Stabilization of iron - complex colors
US4315942A (en) * 1979-05-21 1982-02-16 New England Medical Center, Inc. Intravenously administrable iron supplement
US4311691A (en) * 1979-10-09 1982-01-19 Fichera Anthony T Tobacco smoking inhibitor
EP0094149B1 (fr) * 1982-03-24 1986-09-10 National Research Development Corporation Compositions pharmaceutiques contenant un complexe de fer et de dérivés de 3-hydroxypyrid-2-one ou -4-one substitués à la place N
EP0107458B1 (fr) * 1982-10-22 1987-07-29 National Research Development Corporation Compositions pharmaceutiques
JPH0336807A (ja) * 1989-07-04 1991-02-18 Matsushita Electric Ind Co Ltd 無線機のスピーカ回路

Also Published As

Publication number Publication date
JPS60252414A (ja) 1985-12-13
GB2157563A (en) 1985-10-30
NZ211789A (en) 1988-05-30
GB8410290D0 (en) 1984-05-31
EP0159917A2 (fr) 1985-10-30
EP0159917B1 (fr) 1989-07-19
EP0159917A3 (en) 1986-03-05
DK175685D0 (da) 1985-04-18
US5028411A (en) 1991-07-02
ZA852831B (en) 1986-12-30
AU582510B2 (en) 1989-03-23
AU4141485A (en) 1985-10-24
CA1253803A (fr) 1989-05-09
GB8509814D0 (en) 1985-05-22
GB2157563B (en) 1988-01-27
DK175685A (da) 1985-10-20
DE3571549D1 (en) 1989-08-24

Similar Documents

Publication Publication Date Title
IL74950A (en) Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives
GB8508452D0 (en) Pharmaceutical compositions
GB8403359D0 (en) Pharmaceutical compositions
GB8426672D0 (en) Pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
DE3475706D1 (en) Iron iii complexes of hydroxypyridones, and their pharmaceutical compositions
IL74949A (en) Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing them
NZ210932A (en) Tetrahydro furanylmethyl-substituted-imidazole and-triazole derivatives and fungicidal compositions
GB8403360D0 (en) Pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
GB8503513D0 (en) Pharmaceutical compositions
EP0182611A3 (en) Platinum-phosphine-vinylsiloxane complexes
NZ212976A (en) Amino-anthracenedione-platinum complexes and anti-cancer compositions
NZ211872A (en) Chartreusin derivatives and antitumorous compositions
GB8409961D0 (en) Pharmaceutical compositions
NZ210817A (en) N-hydroxy-alkoxynaphthalinalkanamine derivatives and pharmaceutical compositions
NZ213629A (en) 4,4-diphenylpiperidine derivatives and pharmaceutical compositions
NZ211573A (en) 3-aminopropyloxyphenyl derivatives and pharmaceutical compositions
GB8414959D0 (en) Complexes
ZA851587B (en) Topical pharmaceutical compositions
NZ225464A (en) 1-aminoalkyl-1h-indoles derivatives and pharmaceutical compositions
IE840330L (en) Cationic technetium (i) complexes
IL70868A (en) Pharmaceutical compositions containing a hydroxypyrone complex
GB8427486D0 (en) Pharmaceutical compositions